• From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

  • 2024/08/12
  • 再生時間： 21 分
  • ポッドキャスト

From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).

    The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:

    • Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.
    • The benefits of blood-based biomarkers for Alzheimer’s diagnosis.
    • How better diagnostics will benefit patients.
    • Why we’re on the cusp of a new golden age of neurology
    • How more biomarkers fuel not only better diagnostics but better treatments.
    続きを読む 一部表示

あらすじ・解説

In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).

The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:

  • Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.
  • The benefits of blood-based biomarkers for Alzheimer’s diagnosis.
  • How better diagnostics will benefit patients.
  • Why we’re on the cusp of a new golden age of neurology
  • How more biomarkers fuel not only better diagnostics but better treatments.
続きを読む 一部表示

From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testingに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。